Total Visits
| Views | |
|---|---|
| Safety, ... | 213 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Safety, ... | 0 | 11 | 10 | 13 | 25 | 11 | 15 |
File Visits
| Views | |
|---|---|
| safety_pharmacokinetics_antitumor_activity_anti_ceacam5_dm4_antibody_drug_conjugate_tusamitamab_ravtansine_sar408701_patients_advanced_solid_tumors_first_human_dose_escalation_study_2022.pdf | 208 |
Top country views
| Views | |
|---|---|
| United States | 93 |
| Singapore | 24 |
| France | 18 |
| China | 17 |
| Spain | 16 |
| Germany | 10 |
| Hong Kong | 6 |
| Vietnam | 4 |
| Brazil | 3 |
| United Kingdom | 3 |
Top cities views
| Views | |
|---|---|
| Lauterbourg | 17 |
| Singapore | 13 |
| Ashburn | 12 |
| Boardman | 9 |
| Chandler | 9 |
| Beijing | 8 |
| Boydton | 8 |
| Almont | 7 |
| Orangeburg | 7 |
| Barcelona | 5 |



